Intramedullary rod failure in metastatic breast cancer: Do triple negative cancer patients have more revision surgery?

Ana C. Belzarena, Odion Binitie, Douglas Letson, David M. Joyce

Open source

DOI
10.1016/j.jbo.2021.100358
Published
2021-06
Container
Journal of Bone Oncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jbo.2021.100358,
  title = {Intramedullary rod failure in metastatic breast cancer: Do triple negative cancer patients have more revision surgery?},
  author = {Ana C. Belzarena and Odion Binitie and Douglas Letson and David M. Joyce},
  year = {2021},
  journal = {Journal of Bone Oncology},
  doi = {10.1016/j.jbo.2021.100358},
  url = {https://doi.org/10.1016/j.jbo.2021.100358}
}

RIS

TY  - JOUR
TI  - Intramedullary rod failure in metastatic breast cancer: Do triple negative cancer patients have more revision surgery?
AU  - Ana C. Belzarena
AU  - Odion Binitie
AU  - Douglas Letson
AU  - David M. Joyce
PY  - 2021
JO  - Journal of Bone Oncology
DO  - 10.1016/j.jbo.2021.100358
UR  - https://doi.org/10.1016/j.jbo.2021.100358
ER  - 

APA

Belzarena, A. C., Binitie, O., Letson, D., & Joyce, D. M. (2021). Intramedullary rod failure in metastatic breast cancer: Do triple negative cancer patients have more revision surgery?. Journal of Bone Oncology. https://doi.org/10.1016/j.jbo.2021.100358

Source records